Foxp3+ T-lymphocytes in the pathogenesis of mycosis fungoides
- Authors: Zhukov A.S.1, Belousova I.E.1, Samtsov A.V.1
-
Affiliations:
- Military Medical Academy named after S.M. Kirov Ministry of Defense of the Russion Federation
- Issue: Vol 90, No 5 (2014)
- Pages: 68-72
- Section: ORIGINAL STUDIES
- Submitted: 24.08.2017
- Published: 24.10.2014
- URL: https://vestnikdv.ru/jour/article/view/66
- DOI: https://doi.org/10.25208/0042-4609-2014-90-5-68-72
- ID: 66
Cite item
Full Text
Abstract
The pathogenesis of mycosis fungoides (MF) is not fully understood, nevertheless it is believed that the microenvironment of the tumor cells could influence the development of malignant lymphocytes. T-regulatory cells are a specialized subpopulation of T-lymphocytes, which can have an immunosuppressive effect and thus affect the immune response. Goal. The study population of regulatory T-cells in the skin of patients with mycosis fungoides and llaque parapsoriasis. Materials and methods. The content of Foxp3+ and CD3+ cells by immunohistochemical studies of skin biopsy specimens from patients with patch stage mycosis fungoides (10 patients) and plaque parapsoriasis (10 patients). The control group consisted of 16 healthy individuals. Results. Relative expression area Foxp3+ cells in patients with mycosis fungoides patch stage (0.44%) 2.6 times greater than in patients with plaque parapsoriasis (0,14%; p < 0,05). Part the Foxp3+ cells of the total number of T lymphocytes in patients with patch stage mycosis fungoides (5.9%) and plaque parapsoriasis (4.7%) were not significantly different (p > 0,05). Conclusion. In the initial stage of patients with mycosis fungoides determined a statistically significant predominance of the absolute number of T-regulatory cells in the epidermis and in the dermis. Part T-regulatory cells from all of T-lymphocytes in patients with skin patch stage mycosis fungoides and plaque parapsoriasis not statistically significantly different.
About the authors
A. S. Zhukov
Military Medical Academy named after S.M. Kirov Ministry of Defense of the Russion Federation
Author for correspondence.
Email: md.zhukov@gmail.com
Россия
I. E. Belousova
Military Medical Academy named after S.M. Kirov Ministry of Defense of the Russion Federation
Email: noemail@neicon.ru
Россия
A. V. Samtsov
Military Medical Academy named after S.M. Kirov Ministry of Defense of the Russion Federation
Email: noemail@neicon.ru
Россия
References
- Ackerman A.B. If small plaque (digitate) parapsoriasis is a cutaneous T-cell lymphoma, even an 'abortive’ one, it must be mycosis fungoides! Arch Dermatol 1996; 132: 562-566.
- Babichenko I.I., Kovyazin V.A. New methods of immunohistochemical diagnosis of tumor growth: Tutorial. - Moscow.: RUDN 2008; 109. (Бабиченко И.И., Ковязин В.А. Новые методы иммуногистохимической диагностики опухолевого роста: Учеб. пособие. М: РУДН 2008; 109).
- Berger C.L., Hanlon D., Kanada D. et al. The growth of cutaneous T-cell lymphoma is stimulated by immature dendritic cells. Blood 2002; 99: 2929-2939.
- Fried I., Cerroni L. FOXP3 in sequential biopsies of progressive mycosis fungoides. Am J Dermatopathol 2012 May; 34 (3): 263-5.
- Gjerdrum L.M., Woetmann A., Odum N., Burton C.M., Rossen K., Skovgaard G.L., Ryder L.P., Ralfkiaer E. FOXP3+ regulatory T cells in cutaneous T-cell lymphomas: association with disease stage and survival. Leukemia 2007 Dec; 21 (12): 2512-8.
- Kazakov D.V., Burg G., Kempf W. Clinicopathological spectrum of mycosis fungoides. J Eur Acad Dermatol Venereol 2004 Jul; 18 (4): 397-415.
- Krejsgaard T., Odum N., Geisler C., Wasik M.A., Woetmann A. Regulatory T cells and immunodeficiency in mycosis fungoides and Sézary syndrome. Leukemia 2012 Mar; 26 (3): 424-32.
- Pimpinelli N., Olsen E.A., Santucci M. et al. (2005) Defining early mycosis fungoides. J Am Acad Dermatol 53: 1053-1063.
- Reinhold U., Pawelec G., Fratila A., Leippold S., Bauer R., Kreysel H.W. Phenotypic and functional characterization of tumor infiltrating lymphocytes in mycosis fungoides: continuous growth of CD4+ CD45R+ T-cell clones with suppressor-inducer activity. J Invest Dermatol 1990 Mar; 94 (3): 304-9.
- Sanchez J.L., Ackerman A.B. The patch stage of mycosis fungoides. Am J Dermatopathol 1979; 1: 5-26.
- Thomas B.R., Whittaker S. A practical approach to accurate classification and staging of mycosis fungoides and Sézary syndrome. Skin Therapy Lett 2012 Dec; 17 (10): 5-9.
- Wada D.A., Wilcox R.A., Weenig R.H., Gibson L.E. Paucity of intraepidermal FoxP3-positive T cells in cutaneous T-cell lymphoma in contrast with spongiotic and lichenoid dermatitis. J Cutan Pathol 2010 May; 37 (5): 535-41. (2): 348-58.
- Willemze R., Jaffe E.S., Burg G. et al. WHO-EORTC classification for cutaneous lymphomas. Blood 2005; 105: 3768-85.
- Wilson L.D., Hinds G.A., Yu J.B. Age, race, sex, stage, and incidence of cutaneous lymphoma. Clin Lymphoma Myeloma Leuk 2012 Oct; 12 (5): 291-6.
- Zackheim H.S., McCalmont T.H. Mycosis fungoides: the great imitator. J Am Acad Dermatol 2002 Dec; 47 (6): 914-8.